This Indefinite Delivery Contract (IDC) was awarded by the Defense Health Agency (DHA), a defense agency, to Werfen USA LLC, a Massachusetts-based medical equipment manufacturer. The $643,519.04 single-award contract is for the provision of blood bank reagents, reagents for blood testing for transfusions, over a base period and four option years from April 1, 2023 to September 30, 2027. The contract includes multiple firm fixed-price delivery orders issued to date, including a $68,414.04 order...
The federal contract IDV award is a Blanket Purchase Agreement (BPA) issued by the Defense Health Agency (DHA) to Immucor Inc., a leading provider of automated instrument-reagents systems and consumables for blood transfusion and transplantation compatibility testing. The $1,020,000 single-award BPA, with a period of performance running through March 1, 2027, is intended to facilitate the recurring purchase of essential blood testing products, including reagents, test kits, and diagnostic...
This indefinite delivery contract was awarded to Immucor Inc., a leading provider of automated in vitro diagnostic equipment and consumables for blood transfusion and transplantation compatibility testing. The $127,199.10 contract was awarded by the Veterans Integrated Service Network 9 (VISN 9), a component of the U.S. Department of Veterans Affairs (VA), to provide a base year plus four option years of blood bank reagents and associated supplies to support the VA's blood typing,...
This indefinite delivery contract (IDC) was awarded by the Defense Health Agency (DHA), a defense agency, to Abbott Laboratories Inc., a global healthcare company headquartered in North Chicago, Illinois. The $3,890,514.33 IDC is for the provision of reagents, consumables, and other medical diagnostic products supporting the Alinity S clinical testing platform. The contract does not have a set-aside designation and is a single award. Under this IDC, DHA has issued multiple firm fixed-price...
This federal Indefinite Delivery Contract (IDC) award, with a ceiling value of $4,099,060.31, was made by the Defense Health Agency (DHA) to Abbott Laboratories Inc. (Abbott), a global healthcare company, for the provision of IMMUNOCHEMISTRY REAGENTS. The contract has an ultimate completion date of September 30, 2025 and is a single-award vehicle, with no set-aside designation. Two delivery orders have been issued under this IDC. The first, valued at $1,778,600.15, has a completion date of...
This indefinite delivery contract (IDC) was awarded by the Defense Health Agency (DHA) to Werfen USA LLC, a Bedford, Massachusetts-based manufacturer and supplier of in vitro diagnostic (IVD) equipment, reagents, and services for clinical laboratories and point-of-care medical settings. The $847,255.81 single-award IDC, which runs through April 30, 2030, aims to procure automated blood coagulation and hemostasis testing analyzer reagents and supplies for the DHA. Werfen USA LLC, a for-profit...
This federal contract Indefinite Delivery Vehicle (IDV) is a Blanket Purchase Agreement (BPA) awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network 10 to Immucor Inc., a for-profit manufacturer of goods. The contract has a total ceiling value of $1,880,184.63 and a performance period ending on June 30, 2023. Under this BPA, Immucor, as the prime contractor, will provide a variety of in vitro diagnostic reagents, test kits, and...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Health Agency (DHA), a defense agency, to Ortho-Clinical Diagnostics, Inc., a medical equipment manufacturer. The IDC, valued at $2,282,162.15, is for the procurement of immunoassay testing and related services over a period ending on March 30, 2029. The contract was not set aside for any particular business category. It is a single-award IDC to provide waterless integrated chemistry and immunoassay analyzers, reagents,...
This Indefinite Delivery Contract (IDC) was awarded by the National Institutes of Health (NIH) Clinical Center, a civilian agency, to One Lambda, Inc., a for-profit manufacturer of medical testing reagents and supplies. The $2.1 million single-award IDC covers the delivery of various human leukocyte antigen (HLA) typing and antibody screening reagents to support diagnostics, research protocols, and accreditation maintenance at the NIH Clinical Center through July 2025. No set-aside...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Health Agency (DHA) to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, and laboratory instruments. The $1,774,824.38 ceiling value IDC, which was not set aside, provides Roche's Ventana Medical System reagents and other histology test reagents to the DHA. The contract has a period of performance from October 1, 2021 through September 30, 2026. The task orders issued under...